NCT04947202 (SAFIL_MESH) is a clinical trial of Hernioplasty in Abdominal Wall Defect, sponsored by Aesculap AG.

Who is sponsoring NCT04947202?

NCT04947202 is sponsored by Aesculap AG.

What drugs are being tested in NCT04947202?

Interventions in NCT04947202: Hernioplasty.

What condition does NCT04947202 study?

NCT04947202 studies Abdominal Wall Defect, Ventral Hernia, Abdominal Hernia, Fascial Hernia.

Is NCT04947202 still recruiting?

NCT04947202 is currently completed. Last updated 24 January 2022.

Last reviewed 2022-01-24 · How we verify

NCT04947202: SAFIL_MESH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Study on the Safety of SAFIL® MESH

Completed Last updated 24 January 2022

What this trial tests

trial testing Hernioplasty in Abdominal Wall Defect in 152 participants. Completed in 30 November 2021.

Timeline

1 July 2021

Primary endpoint
30 November 2021

30 November 2021

Quick facts

Lead sponsor	Aesculap AG
Status	Completed
Study type	OBSERVATIONAL
Enrollment	152
Start date	1 July 2021
Primary completion	30 November 2021
Estimated completion	30 November 2021
Sites	2 locations across Spain

Drugs / interventions tested

Hernioplasty

Conditions studied

Abdominal Wall Defect — all drugs for Abdominal Wall Defect →
Ventral Hernia — all drugs for Ventral Hernia →
Abdominal Hernia — all drugs for Abdominal Hernia →
Fascial Hernia — all drugs for Fascial Hernia →

Sponsor

Aesculap AG — full company profile →

Who can join

Eligibility, any sex, with Abdominal Wall Defect or Ventral Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Observational, Retrospective, Multi-center Clinical Study on the Safety of SAFIL® MESH in Patients Undergoing Reinforcement of Soft Tissues After Abdominal Wall Surgery or Other Fascial Defects

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Abdominal Wall Defect

Currently open trials in the same condition.

NCT06367309 — ExtrAperitoneaL Plasty vs Intraperitoneal oNlay mEsh in Ventral Hernia Repair · NA · recruiting
NCT03310905 — Abdominal Wall Transplant · NA · recruiting

Other Aesculap AG trials

Trials by the same sponsor.

NCT05441618 — Post Market Clinical Follow-Up Study on the Performance and Safety of Lyoplant® · completed
NCT05944081 — Postmarket Clinical Follow-Up Study on Arcadius XP L® Interbody Fusion Device · withdrawn
NCT06298500 — Clinical Performance of HISTOACRYL® LAPFIX - CANNULA for Laparoscopic Inguinal Hernia Repair · completed
NCT06055946 — Symmcora® Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical Prostatect · completed
NCT05182320 — Study Measuring the Effects of Patient Data for Total Hip and Total Knee Arthroplasty Patients Using an APP Based Sensor · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04947202 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aesculap AG
Last refreshed: 24 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04947202.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing